Azaperone

DB11376InvestigationalVet approvedSmall molecule

Azaperone is a pyridinylpiperazine and butyrophenone agent that is capable of eliciting neuroleptic sedative and antiemetic effects. It is subsequently employed predominantly as a veterinary tranquilizer and mainly for pigs... At the same time, the agent generally does not see equine use as particular adverse reactions may happen.

Chemical structure of Azaperone
Formula / weight
C19H22FN3O · 327.403 g/mol (avg)
Also known as
Azaperon
Code names
NSC-170976 · R-1929

Resolves to

Compound
UNII19BV78AK7WCAS1649-18-9ChEMBLCHEMBL340211ChEBI88301KEGGD02620
Clinical / RWD
RxNorm2601502
Structure
InChIKeyXTKDAFGWCDAMPY-UHFFFAOYSA-NSMILESFC1=CC=C(C=C1)C(=O)CCCN1CCN(CC1)C1=CC=CC=N1
Targets
P14416DRD2P35462DRD3

What you can answer from here — as of January 29, 2025

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
752Drug interactionsStructured to mechanism, not free text
Sign in
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
1Marketed productAcross 1 country and 1 labeller
Sign in
37+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Azaperone, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In